Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Transplantation. 2013 Sep 15;96(5):487-93. doi: 10.1097/TP.0b013e31829acb10.
Living-donor kidney transplantation (KT) is encouraged for children with end-stage renal disease due to superior long-term graft survival compared with deceased-donor KT. Despite this, there has been a steady decrease in the use of living-donor KT for pediatric recipients. Due to their young age at transplantation, most pediatric recipients eventually require retransplantation, and the optimal order of donor type is not clear.
Using the Scientific Registry of Transplant Recipients, we analyzed first and second graft survival among 14,799 pediatric (<18 years old) recipients undergoing KT between 1987 and 2010.
Living-donor grafts had longer survival compared with deceased-donor grafts, similarly among both first (adjusted hazard ratio [aHR], 0.78; 95% confidence interval [CI], 0.73-0.84; P<0.001) and second (aHR, 0.74; 95% CI, 0.64-0.84; P<0.001) transplants. Living-donor second grafts had longer survival compared with deceased-donor second grafts, similarly after living-donor (aHR, 0.68; 95% CI, 0.56-0.83; P<0.001) and deceased-donor (aHR, 0.77; 95% CI, 0.63-0.95; P=0.02) first transplants. Cumulative graft life of two transplants was similar regardless of the order of deceased-donor and living-donor transplantation.
Deceased-donor KT in pediatric recipients followed by living-donor retransplantation does not negatively impact the living-donor graft survival advantage and provides similar cumulative graft life compared with living-donor KT followed by deceased-donor retransplantation. Clinical decision-making for pediatric patients with healthy, willing living donors should consider these findings in addition to the risk of sensitization, aging of the living donor, and deceased-donor waiting times.
与已故供者肾移植(KT)相比,活体供者肾移植(KT)可为终末期肾病的儿童提供更优的长期移植物存活率,因此鼓励采用活体供者 KT 治疗儿童。尽管如此,活体供者 KT 在儿科受者中的应用却呈稳步下降趋势。由于大多数儿科受者在移植时年龄较小,最终需要再次移植,而且供者类型的最佳顺序尚不清楚。
利用美国移植受者科学登记处的数据,我们分析了 1987 年至 2010 年间 14799 名(<18 岁)接受 KT 的儿童的首次和二次移植物存活率。
活体供者移植物的存活率长于已故供者移植物,在首次(调整后的危害比[aHR],0.78;95%置信区间[CI],0.73-0.84;P<0.001)和二次(aHR,0.74;95%CI,0.64-0.84;P<0.001)移植中均如此。活体供者的二次移植物的存活率长于已故供者的二次移植物,且在活体供者(aHR,0.68;95%CI,0.56-0.83;P<0.001)和已故供者(aHR,0.77;95%CI,0.63-0.95;P=0.02)首次移植后也如此。无论已故供者和活体供者移植的顺序如何,两次移植的移植物总生存时间相似。
在儿科受者中首先进行已故供者 KT 然后进行活体供者再次移植不会对活体供者移植物存活率优势产生负面影响,并且与首先进行活体供者 KT 然后进行已故供者再次移植相比,可提供相似的移植物总生存时间。对于有健康、愿意活体供者的儿科患者,在进行临床决策时,除了要考虑致敏风险、活体供者的衰老和已故供者的等待时间外,还应考虑这些发现。